Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 2
2009 3
2010 2
2011 5
2012 4
2013 2
2014 4
2015 2
2016 2
2017 7
2018 6
2019 9
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
Peres FF, Lima AC, Hallak JEC, Crippa JA, Silva RH, Abílio VC. Peres FF, et al. Front Pharmacol. 2018 May 11;9:482. doi: 10.3389/fphar.2018.00482. eCollection 2018. Front Pharmacol. 2018. PMID: 29867488 Free PMC article. Review.
Movement disorders such as Parkinson's disease and dyskinesia are highly debilitating conditions linked to oxidative stress and neurodegeneration. ...Here, we review these clinical and pre-clinical studies and draw attention to the potential of cannabidiol in this f …
Movement disorders such as Parkinson's disease and dyskinesia are highly debilitating conditions linked to oxidative stress and neurodege
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid.
Kozela E, Juknat A, Vogel Z. Kozela E, et al. Int J Mol Sci. 2017 Jul 31;18(8):1669. doi: 10.3390/ijms18081669. Int J Mol Sci. 2017. PMID: 28788104 Free PMC article. Review.
Cannabidiol (CBD) is the main non-psychotomimetic cannabinoid derived from Cannabis. CBD is devoid of direct CB1 and CB2 receptor activity, but exerts a number of important effects in the brain. ...The collected data shows that increased astrocyte activity is suppressed in
Cannabidiol (CBD) is the main non-psychotomimetic cannabinoid derived from Cannabis. CBD is devoid of direct CB1 and CB2 receptor act
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.
Karl T, Garner B, Cheng D. Karl T, et al. Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):142-160. doi: 10.1097/FBP.0000000000000247. Behav Pharmacol. 2017. PMID: 27471947 Review.
AD brains also show neurodegeneration and high levels of oxidative stress and inflammation. The phytocannabinoid cannabidiol (CBD) possesses neuroprotective, antioxidant and anti-inflammatory properties and reduces amyloid-β production and tau hyperphosphorylation i …
AD brains also show neurodegeneration and high levels of oxidative stress and inflammation. The phytocannabinoid cannabidiol ( …
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol.
da Silva VK, de Freitas BS, Dornelles VC, Kist LW, Bogo MR, Silva MC, Streck EL, Hallak JE, Zuardi AW, Crippa JAS, Schröder N. da Silva VK, et al. Brain Res Bull. 2018 May;139:1-8. doi: 10.1016/j.brainresbull.2018.01.014. Epub 2018 Jan 31. Brain Res Bull. 2018. PMID: 29374603 Free article.
Evidence has demonstrated iron accumulation in specific brain regions of patients suffering from neurodegenerative disorders, and this metal has been recognized as a contributing factor for neurodegeneration. ...The present study aims to characterize iron loading effects a …
Evidence has demonstrated iron accumulation in specific brain regions of patients suffering from neurodegenerative disorders, and this metal …
Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.
Philpott HT, OʼBrien M, McDougall JJ. Philpott HT, et al. Pain. 2017 Dec;158(12):2442-2451. doi: 10.1097/j.pain.0000000000001052. Pain. 2017. PMID: 28885454 Free PMC article.
Osteoarthritis (OA) is a multifactorial joint disease, which includes joint degeneration, intermittent inflammation, and peripheral neuropathy. ...Joint nerve myelination was calculated by G-ratio analysis. The therapeutic and prophylactic effects of peripheral CBD …
Osteoarthritis (OA) is a multifactorial joint disease, which includes joint degeneration, intermittent inflammation, and peripheral n …
Cannabidiol: a promising drug for neurodegenerative disorders?
Iuvone T, Esposito G, De Filippis D, Scuderi C, Steardo L. Iuvone T, et al. CNS Neurosci Ther. 2009 Winter;15(1):65-75. doi: 10.1111/j.1755-5949.2008.00065.x. CNS Neurosci Ther. 2009. PMID: 19228180 Free PMC article. Review.
It is believed that this nerve cell loss underlies the subsequent decline in cognitive and motor function that patients experience in these diseases. ...Nevertheless, among Cannabis compounds, cannabidiol (CBD), which lacks any unwanted psychotropic effect, may repr …
It is believed that this nerve cell loss underlies the subsequent decline in cognitive and motor function that patients experience in …
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.
Osborne AL, Solowij N, Weston-Green K. Osborne AL, et al. Neurosci Biobehav Rev. 2017 Jan;72:310-324. doi: 10.1016/j.neubiorev.2016.11.012. Epub 2016 Nov 22. Neurosci Biobehav Rev. 2017. PMID: 27884751 Review.
Cannabidiol (CBD), a component of the cannabis plant, has anti-inflammatory and antipsychotic-like properties; however, its ability to improve cognitive impairment has not been thoroughly explored. ...
Cannabidiol (CBD), a component of the cannabis plant, has anti-inflammatory and antipsychotic-like properties; however, its ability t
Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol.
Mammana S, Cavalli E, Gugliandolo A, Silvestro S, Pollastro F, Bramanti P, Mazzon E. Mammana S, et al. Medicina (Kaunas). 2019 Nov 18;55(11):747. doi: 10.3390/medicina55110747. Medicina (Kaunas). 2019. PMID: 31752240 Free PMC article.
In this study, we investigate the anti-inflammatory, anti-oxidant, and anti-apoptotic properties of two non-psychoactive phytocannabinoids, cannabigerol (CBG) and cannabidiol (CBD). Materials and Methods: The motoneuron-like cell line NSC-34 differentiated by serum depriva …
In this study, we investigate the anti-inflammatory, anti-oxidant, and anti-apoptotic properties of two non-psychoactive phytocannabinoids, …
Cannabinoids Δ(9)-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-κB signaling.
Majdi F, Taheri F, Salehi P, Motaghinejad M, Safari S. Majdi F, et al. Med Hypotheses. 2019 Dec;133:109371. doi: 10.1016/j.mehy.2019.109371. Epub 2019 Aug 19. Med Hypotheses. 2019. PMID: 31465975
The neurodegeneration, neuro-inflammation and mitochondrial dysfunction which occur by methamphetamine (METH) abuse or administration are serious and motivation therapeutic approaches for inhibition of these types of neurodegeneration. ...Previous studies have state …
The neurodegeneration, neuro-inflammation and mitochondrial dysfunction which occur by methamphetamine (METH) abuse or administration …
Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer's Disease.
Hughes B, Herron CE. Hughes B, et al. Neurochem Res. 2019 Mar;44(3):703-713. doi: 10.1007/s11064-018-2513-z. Epub 2018 Mar 24. Neurochem Res. 2019. PMID: 29574668
Here we demonstrate for the first time that cannabidiol (CBD) acts to protect synaptic plasticity in an in vitro model of Alzheimer's disease (AD). The non-psycho active component of Cannabis sativa, CBD has previously been shown to protect against the neurotoxic effects o …
Here we demonstrate for the first time that cannabidiol (CBD) acts to protect synaptic plasticity in an in vitro model of Alzheimer's …
51 results
Jump to page
Feedback